Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a stable position within the medical device industry, despite a slight decline in revenue [1] - As of July 1, Yirui Technology's closing price was 88.5 yuan, with a PE ratio of 37.78 times and a total market capitalization of 17.719 billion yuan [1] - The average PE ratio for the medical device industry is 51.70 times, with a median of 37.36 times, positioning Yirui Technology at the 77th rank within the industry [1][2] Group 2 - Yirui Technology reported a revenue of 482 million yuan for Q1 2025, reflecting a year-on-year decrease of 1.92%, while net profit was 143 million yuan, showing a year-on-year increase of 2.74% [1] - The company's gross profit margin stands at 48.92% [1] - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan per shareholder [1]

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-047 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于可转债转股结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 累计转股情况：截止2025年6月30日，"奕瑞转债"累计有人民币13,275,000 元已转换为奕瑞电子科技集团股份有限公司（以下简称"公司"）股票，转股数量 为57,686股，占"奕瑞转债"转股前公司已发行股份总额的0.0567%； 未转股可转债情况：截止2025年6月30日，"奕瑞转债"尚未转股的可转债 金额为1,421,735,000元，占"奕瑞转债"发行总量的99.0749%； 本季度转股情况：自2025年4月1日起至2025年6月30日，"奕瑞转债"共有 人民币1,000元已转换为公司股票，转股数量为6股，占"奕瑞转债"转股前公司已 发行股份总额的0.0000%。 一、可转债发行上市概况 经中国证券监 ...

Overview - The report discusses the share transfer of Yirui Electronic Technology Group Co., Ltd. (Yirui Technology) by its shareholder Hainan Heyi Investment Co., Ltd. to specific institutional investors through a price inquiry method before the company's initial public offering (IPO) on the Sci-Tech Innovation Board [1][8]. Share Transfer Details - The maximum number of shares to be transferred in this inquiry is 6,122,448 shares, which represents 3.06% of the total share capital of Yirui Technology as of June 20, 2025 [1][6]. - Hainan Heyi holds 34.31% of the shares prior to the IPO [1]. Pricing Mechanism - The price floor for the share transfer is set at no less than 70% of the average trading price of Yirui Technology's shares over the 20 trading days preceding June 20, 2025 [2]. - The final transfer price is determined through a competitive bidding process, with a final price set at 75.86 CNY per share, leading to a total subscription amount of approximately 464.45 million CNY [6][7]. Participation and Allocation - A total of 95 institutional investors were invited to participate in the inquiry, including 18 fund management companies, 14 securities firms, and 49 private fund managers [5]. - The final allocation of shares was made to 22 institutional investors, with the total number of shares allocated being 6,122,448 [6][7]. Compliance and Verification - The inquiry transfer process was verified to be legal and compliant with relevant regulations, including the Company Law and Securities Law of the People's Republic of China [8][14]. - Both the transferor and transferee were confirmed to meet the qualifications required by the inquiry transfer guidelines [10][13].

Summary of Key Points Core Viewpoint - The report details the results of a share transfer by Hainan Heyi Investment Co., Ltd., which sold 6,122,448 shares of Yirui Technology at a price of 75.86 yuan per share, reducing its stake from 8.91% to 5.85% without affecting the control of the company [1][2][3]. Group 1: Transfer Details - The transfer price was set at 75.86 yuan per share for a total of 6,122,448 shares [1][3]. - Hainan Heyi's shareholding decreased from 8.91% to 5.85%, resulting in a total of 11,721,318 shares held post-transfer [2][3]. - The transfer does not lead to any change in the company's controlling shareholder or actual controller [1][4]. Group 2: Transferor Information - Hainan Heyi Investment Co., Ltd. is identified as a significant shareholder, holding more than 5% of the company's shares, but is not the controlling shareholder [1][2]. - There are no concerted action relationships associated with the transferor [1][2]. Group 3: Transfer Process - The transfer process involved a price negotiation based on the company's funding needs and was conducted through a fair and transparent inquiry process [3][5]. - A total of 35 valid subscription bids were received from institutional investors, with 22 investors ultimately allocated shares [3][5].

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-046 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 股东询价转让结果报告书暨持股 5%以上股东权益变动 触及 1%的提示性公告 股东海南合毅投资有限公司保证向奕瑞电子科技集团股份有限公司提供的信息 内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性和完 整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 奕瑞电子科技集团股份有限公司（以下简称"公司"、"奕瑞科技"）控股股 东、实际控制人不参与本次询价转让。 本次转让不会导致公司控股股东、实际控制人发生变化。 转让方海南合毅持股比例由8.91%增加至5.85%。 一、 转让方情况 (一) 转让方基本情况 截至 2025 年 6 月 20 日，转让方所持公司首发前股份的数量、占总股本比例情 况如下： | 序号 | 股东名称 | 持股数量（股） | 持股占总股本比例 | | --- | --- | --- | --- | | 1 | 海南合毅 ...

证券代码：688301 证券简称：奕瑞科技 可转债代码：118025 可转债简称：奕瑞转债 奕瑞电子科技集团股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024 年度） 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》（以下简称"《管理办 法》"）、《上海奕瑞光电子科技股份有限公司向不特定对象发行可转换公司 债券之债券受托管理协议》（以下简称"《受托管理协议》"）、《上海奕瑞 光电子科技股份有限公司向不特定对象发行可转换公司债券募集说明书》（以 下简称"《募集说明书》"）、《奕瑞电子科技集团股份有限公司 2024 年年度 报告》等相关公开信息披露文件、第三方中介机构出具的专业意见等，由本期 债券受托管理人中国国际金融股份有限公司（以下简称"中金公司"）编制。 中金公司对本报告中所包含的从上述文件中引述内容和信息未进行独立验证， 也不就该等引述内容和信息的真实性、准确性和完整性做出任何保证或承担任 何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相 关事宜做出独立判断，而不应将本报告中的任何内容据以作为中金公司所作的 承诺或声明。在 ...

中国国际金融股份有限公司 关于奕瑞电子科技集团股份有限公司股东 向特定机构投资者询价转让股份的核查报告 中国国际金融股份有限公司（以下简称"中金公司""组织券商"）受奕瑞电 子科技集团股份有限公司（以下简称"奕瑞科技""上市公司"）股东海南合毅 投资有限公司（以下简称"海南合毅""转让方"）委托，组织实施本次奕瑞科 技首次公开发行股票并在科创板上市前股东向特定机构投资者询价转让（以下简 称"本次询价转让"）。 经核查，中金公司就本次询价转让的转让方、受让方是否符合《上海证券交 易所科创板上市公司自律监管指引第 4 号——询价转让和配售》（以下简称"《询 价转让和配售指引》"）要求，本次询价转让的询价、转让过程与结果是否公平、 公正，是否符合《询价转让和配售指引》的规定作出如下报告说明。 1 （三）转让方式 转让方作为上海证券交易所科创板上市公司奕瑞科技首发前股东，根据《询 价转让和配售指引》有关规定以向特定机构投资者询价转让方式转让股份。 （四）本次询价转让价格下限确定原则 一、本次询价转让概述 （一）本次询价转让转让方 截至 2025 年 6 月 20 日，转让方所持公司股份的数量、比例情况如下： | 序号 ...

Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a competitive position within the medical device industry, despite a slight decline in stock price and revenue [1] - As of June 26, Yirui Technology's closing price was 88.77 yuan, down 1.31%, with a rolling PE ratio of 37.90 times and a total market capitalization of 17.773 billion yuan [1] - The average PE ratio for the medical device industry is 49.45 times, with a median of 35.92 times, positioning Yirui Technology at the 80th rank within the industry [1][2] Group 2 - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The main business of Yirui Technology includes the research, production, sales, and service of digital X-ray detectors, high-voltage generators, and other core components [1] - In the latest quarterly report for Q1 2025, Yirui Technology reported an operating income of 482 million yuan, a year-on-year decrease of 1.92%, and a net profit of 143 million yuan, a year-on-year increase of 2.74%, with a gross profit margin of 48.92% [1]

Core Viewpoint - The credit rating agency maintains the credit rating of Yirui Technology Group Co., Ltd. at AA with a stable outlook, indicating strong financial health and operational performance in the digital X-ray detector industry [1][8]. Company Overview - Yirui Technology primarily engages in the research, production, and sales of digital X-ray detectors, and is one of the few manufacturers globally capable of mass production of amorphous silicon, IGZO, CMOS, and flexible substrate sensor technologies [9][11]. - As of March 2025, the company's total assets amounted to 91.34 billion yuan, with total liabilities at 35.81 billion yuan and equity at 47.83 billion yuan [12]. Financial Performance - The company reported total revenue of 18.31 billion yuan in 2024, with a profit of 5.07 billion yuan, reflecting a slight decline in revenue compared to the previous year [8][12]. - The gross profit margin remains high, although there was a decrease in revenue from digital X-ray detectors by 12.04% due to increased market competition and economic factors [21]. Market Position and Growth - The global digital X-ray detector market is expected to grow, driven by advancements in technology and increasing demand in the medical sector, with a projected market size of 50.3 billion USD by 2030 [16][19]. - The company has established a strong market presence in the medical and industrial sectors, with significant sales growth in new core components and comprehensive solutions [9][21]. Investment and Projects - The company issued 14.35 billion yuan in convertible bonds to fund projects related to new detector technologies and the establishment of a comprehensive innovation base [13]. - The projects are expected to enhance production capacity significantly, with an anticipated increase of 32,000 units for CMOS detectors and 2,000 units for CT detectors upon completion [13]. Industry Analysis - The digital X-ray detector industry is characterized by high technical barriers and a concentrated market, with major players including both domestic and international firms [20][21]. - The industry is poised for growth as domestic manufacturers improve their R&D capabilities, potentially leading to a shift in global production bases for X-ray core components [21].

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-045 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 股东询价转让定价情况提示性公告 股东海南合毅投资有限公司保证向奕瑞电子科技集团股份有限公司提供的 信息内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确 性和完整性依法承担法律责任。 重要内容提示： 根据 2025 年 6 月 23 日询价申购情况，初步确定的奕瑞电子科技集团股 份有限公司（以下简称"公司"）股东询价转让（以下简称"本次询价转让"）的 转让价格为 75.86 元/股。 受让方通过询价转让受让的股份，在受让后 6 个月内不得转让。 一、本次询价转让初步定价 （一）经向机构投资者询价，初步确定的转让价格为 75.86 元/股。 （二）参与本次询价转让报价的机构投资者共 29 家，涵盖了基金管理公司、 保险公司、证券公司、期货公司、合格境外投资者、私募基金管理人等专业机构 投资者。参与本次询价转让报价的机构投资者合计有效认购股份数量为 1,164 万 股，对应的有效认购 ...